INTRODUCTION: Perfusion (Q) single photon emission computed tomography (SPECT) has been used to divert dose away from higher-functioning lung during radiation therapy (RT) planning. This study aimed to (1) study regional lung function through coregistered pulmonary ventilation/perfusion (V/Q)-SPECT-CT and (2) classify these defects for its potential value in radiation planning in patients with non-small cell lung cancer (NSCLC). METHODS: Patients with stages I to III NSCLC requiring radiation-based therapy were eligible for this prospective study. V/Q-SPECT performed within 2 weeks before the start of radiation was interpreted by nuclear medicine physicians and then measured by a semiquantitative score. The potential mechanism of V and Q defects was analyzed; the potential impact of V/Q-SPECT over Q-SPECT alone was completed through classified applications (high-dose RT versus RT avoidance) during planning. RESULTS: Images of 51 consecutive patients were analyzed. The V and Q defects were matched, reverse mismatched (V defect > Q defect), and mismatched (Q defect > V defect) in 61, 31, and 8% of patients, respectively. Tumor was the leading cause of the defects of ipsilateral lung in 73% of patients. The defect scores of the ipsilateral lung were greater in patients with central primaries than those with peripheral primaries for both V-SPECT (2.3 ± 1.1 versus 1.5 ± 0.8, p = 0.017) and Q-SPECT (2.2 ± 0.8 versus 1.4 ± 0.6, p = 0.000). The patients with chronic obstructive pulmonary disease had greater defect scores in contralateral lung for both V-SPECT (1.5 ± 0.7 versus 1.0 ± 0.8, p = 0.006) and Q-SPECT (1.4 ± 0.6 versus 1.0 ± 0.4, p = 0.010). On assessing the potential value of SPECT on RT plan, 39% of patients could have their RT plan when applying V/Q-SPECT rather than Q-SPECT alone. CONCLUSIONS: V/Q-SPECT provides a more comprehensive functional assessment, may provide additional value over Q-SPECT alone in assessing local pulmonary function, and guide RT plan decisions in patients with NSCLC.
INTRODUCTION: Perfusion (Q) single photon emission computed tomography (SPECT) has been used to divert dose away from higher-functioning lung during radiation therapy (RT) planning. This study aimed to (1) study regional lung function through coregistered pulmonary ventilation/perfusion (V/Q)-SPECT-CT and (2) classify these defects for its potential value in radiation planning in patients with non-small cell lung cancer (NSCLC). METHODS:Patients with stages I to III NSCLC requiring radiation-based therapy were eligible for this prospective study. V/Q-SPECT performed within 2 weeks before the start of radiation was interpreted by nuclear medicine physicians and then measured by a semiquantitative score. The potential mechanism of V and Q defects was analyzed; the potential impact of V/Q-SPECT over Q-SPECT alone was completed through classified applications (high-dose RT versus RT avoidance) during planning. RESULTS: Images of 51 consecutive patients were analyzed. The V and Q defects were matched, reverse mismatched (V defect > Q defect), and mismatched (Q defect > V defect) in 61, 31, and 8% of patients, respectively. Tumor was the leading cause of the defects of ipsilateral lung in 73% of patients. The defect scores of the ipsilateral lung were greater in patients with central primaries than those with peripheral primaries for both V-SPECT (2.3 ± 1.1 versus 1.5 ± 0.8, p = 0.017) and Q-SPECT (2.2 ± 0.8 versus 1.4 ± 0.6, p = 0.000). The patients with chronic obstructive pulmonary disease had greater defect scores in contralateral lung for both V-SPECT (1.5 ± 0.7 versus 1.0 ± 0.8, p = 0.006) and Q-SPECT (1.4 ± 0.6 versus 1.0 ± 0.4, p = 0.010). On assessing the potential value of SPECT on RT plan, 39% of patients could have their RT plan when applying V/Q-SPECT rather than Q-SPECT alone. CONCLUSIONS: V/Q-SPECT provides a more comprehensive functional assessment, may provide additional value over Q-SPECT alone in assessing local pulmonary function, and guide RT plan decisions in patients with NSCLC.
Authors: Giuliano Mariani; Laura Bruselli; Torsten Kuwert; Edmund E Kim; Albert Flotats; Ora Israel; Maurizio Dondi; Naoyuki Watanabe Journal: Eur J Nucl Med Mol Imaging Date: 2010-02-25 Impact factor: 9.236
Authors: Iram Munawar; Brian P Yaremko; Jeff Craig; Michael Oliver; Stewart Gaede; George Rodrigues; Edward Yu; Robert Henderson Reid; Eugene Leung; Jean-Luc Urbain; Jeff Chen; Eugene Wong Journal: Med Phys Date: 2010-04 Impact factor: 4.071
Authors: Junan Zhang; Jinli Ma; Sumin Zhou; Jessica L Hubbs; Terence Z Wong; Rodney J Folz; Elizabeth S Evans; Ronald J Jaszczak; Robert Clough; Lawrence B Marks Journal: Int J Radiat Oncol Biol Phys Date: 2009-07-23 Impact factor: 7.038
Authors: Roberto Rodríguez-Roisin; Mitra Drakulovic; Diego A Rodríguez; Josep Roca; Joan Albert Barberà; Peter D Wagner Journal: J Appl Physiol (1985) Date: 2009-04-16
Authors: Emma L Bates; Christopher M Bragg; Jim M Wild; Matthew Q F Hatton; Rob H Ireland Journal: Radiother Oncol Date: 2009-06-22 Impact factor: 6.280
Authors: Faegheh S Mounessi; Jörg Eckardt; Arne Holstein; Santiago Ewig; Stefan Könemann Journal: Strahlenther Onkol Date: 2019-10-02 Impact factor: 3.621
Authors: Shuanghu Tiger Yuan; Kirk A Frey; Milton D Gross; James A Hayman; Doug Arenberg; Xu-Wei Cai; Nithya Ramnath; Khaled Hassan; Jean Moran; Avraham Eisbruch; Randall K Ten Haken; Feng-Ming Spring Kong Journal: Int J Radiat Oncol Biol Phys Date: 2011-12-22 Impact factor: 7.038
Authors: Katherina P Farr; Stine Kramer; Azza A Khalil; Anni Morsing; Cai Grau Journal: Eur J Nucl Med Mol Imaging Date: 2015-04-11 Impact factor: 9.236
Authors: Joshua R Astley; Alberto M Biancardi; Paul J C Hughes; Helen Marshall; Laurie J Smith; Guilhem J Collier; James A Eaden; Nicholas D Weatherley; Matthew Q Hatton; Jim M Wild; Bilal A Tahir Journal: Sci Rep Date: 2022-06-22 Impact factor: 4.996
Authors: Michael MacManus; Sarah Everitt; Tanja Schimek-Jasch; X Allen Li; Ursula Nestle; Feng-Ming Spring Kong Journal: Transl Lung Cancer Res Date: 2017-12
Authors: Zhuorui Li; Pierre-Yves Le Roux; Jason Callahan; Nicholas Hardcastle; Michael S Hofman; Shankar Siva; Tokihiro Yamamoto Journal: Phys Imaging Radiat Oncol Date: 2022-04-11
Authors: Esther M Vicente; Arezoo Modiri; John Kipritidis; Kun-Chang Yu; Kai Sun; Jochen Cammin; Arun Gopal; Jingzhu Xu; Sina Mossahebi; Aaron Hagan; Yulong Yan; Daniel Rockwell Owen; Pranshu Mohindra; Martha M Matuszak; Robert D Timmerman; Amit Sawant Journal: Int J Radiat Oncol Biol Phys Date: 2022-03-09 Impact factor: 8.013